Short Interest in Xenetic Biosciences, Inc. (NASDAQ:XBIOW) Declines By 50.0%

Xenetic Biosciences, Inc. (NASDAQ:XBIOW) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 200 shares, a decrease of 50.0% from the March 31st total of 400 shares. Based on an average daily volume of 300 shares, the short-interest ratio is currently 0.7 days.

Xenetic Biosciences Stock Performance

Shares of NASDAQ:XBIOW opened at $7.46 on Friday. Xenetic Biosciences has a 1 year low of $0.70 and a 1 year high of $23.16. The firm has a fifty day moving average price of $11.57 and a 200 day moving average price of $8.09.

About Xenetic Biosciences

Xenetic Biosciences, Inc, a biopharmaceutical company, focuses on advancing immune-oncology technologies for hard to treat cancers. The company's proprietary DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments that targets pancreatic cancer comprising pancreatic ductal adenocarcinoma, colorectal carcinoma, and other gastrointestinal cancer.